## **Core Concept**
Dysgerminoma of the ovary is a type of germ cell tumor that primarily affects young women. It is known for its association with certain tumor markers, which are substances produced by the tumor or in response to the tumor's presence. Tumor markers are crucial for diagnosis, monitoring treatment response, and detecting recurrence.

## **Why the Correct Answer is Right**
The correct answer, **LDH (Lactate Dehydrogenase)**, is associated with dysgerminoma because this enzyme is often elevated in the serum of patients with this type of tumor. LDH is a cytoplasmic enzyme found in nearly all living cells, and its elevation can indicate tissue damage or disease, including malignancy. Dysgerminomas, being highly malignant but also highly responsive to treatment, can cause an increase in LDH levels, making it a useful marker for monitoring disease activity.

## **Why Each Wrong Option is Incorrect**
- **Option A: CA-125** - While CA-125 is a commonly elevated tumor marker in ovarian cancer, it is more commonly associated with epithelial ovarian cancers rather than germ cell tumors like dysgerminoma.
- **Option B: AFP (Alpha-fetoprotein)** - AFP is primarily associated with yolk sac tumors and some other germ cell tumors but not typically with dysgerminomas.
- **Option C: β-hCG (beta-human chorionic gonadotropin)** - β-hCG is elevated in choriocarcinomas and some other germ cell tumors but is not the primary marker for dysgerminomas.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that dysgerminomas are highly sensitive to chemotherapy and radiotherapy, which is fortunate given their potential for malignancy. Monitoring LDH levels can help in assessing the response to treatment and in detecting recurrence early.

## **Correct Answer: D. LDH.**